MAP3K11 and breast carcinoma: MLK3 knockdown or pharmacologic inhibition of MLK3 has been shown to block the migratory activity of breast cancer cells in in vitro wound healing assays [8], [15], and to also prevent the in vivo metastasis of MDA-MB-231 cells from the breast fat pad to the lung [15] and to distant lymph nodes [11].